Sort
64,565 grants matching “drug discovery”
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
$698,710Joseph D Smith · Seattle Children'S Hospital · R01 · FY2021 · AI
Optimization of Atypical Antimycobacterial Carbapenem Antibiotics
$698,616John D Buynak · Southern Methodist University · R01 · FY2024 · AI
Structural Basis of Signal Instigation Through Family C GPCRs
$698,575Georgios Skiniotis · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
MRI: Acquisition of a Scanning X-Ray Photoelectron Spectroscopy Microprobe for Fundamental and Applied Materials Research, Education, and Outreach
$698,545Filippo Mangolini · University Of Texas At Austin · · FY2021 · MPS
NCI Pediatric In Vivo Testing Program: Neuroblastoma
$698,544Yael P Mosse · Children'S Hosp Of Philadelphia · U01 · FY2022 · CA
Targeted discovery of antibiotics from cave bacteria
$698,536Joseph A Pogliano · University Of California, San Diego · R01 · FY2019 · AI
Signal Transduction by Tyrosine Phosphorylation
$698,480Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2010 · CA
Behavioral Phenotyping Core
$698,478Leona Gagnon · Jackson Laboratory · P50 · FY2025 · DA
Protein structural biophysics driving drug discovery for cardiac calcium transport regulation, producing translational advances and mechanistic insights
$698,443David Dale Thomas · University Of Minnesota · R01 · FY2024 · HL
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy
$698,412Calvin J Kuo · Stanford University · R01 · FY2019 · DK
Synthetic biology tools for scalable production of medicinal plant terpenes
$698,322Elizabeth Susan Sattely · Stanford University · R01 · FY2021 · AT
Genetic Susceptibility To Carcinogens
$698,262Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Functional consequences of cancer mutations
$698,187Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
UC San Diego Clinical and Translational Research Institute
$698,152Colin A Depp · University Of California, San Diego · TL1 · FY2019 · TR
Genotype-guided therapy for atrial fibrillation
$698,017Dawood Darbar · University Of Illinois At Chicago · R01 · FY2023 · HL
Genotype-guided therapy for atrial fibrillation
$698,017Dawood Darbar · University Of Illinois At Chicago · R01 · FY2022 · HL
Biosynthesis of Beta-Lactam Antibiotics
$698,007Craig A Townsend · Johns Hopkins University · R37 · FY2009 · AI
Curaxin-137, A New Lead for Anti-Trypanosome Drug Discovery - Resubmission - 1
$697,985Kojo Mensa-Wilmot · University Of Georgia · R01 · FY2017 · AI
Indiana University Center for Pediatric Pharmacology and Precision Medicine
$697,951Jamie L Renbarger · Indiana University Indianapolis · P50 · FY2019 · HD
Non-Melanoma Skin Cancer in New Hampshire
$697,929Margaret Rita Karagas · Dartmouth College · R01 · FY2013 · CA
UT Southwestern NCI National Clinical Trials Network (NCTN) LAPS - Funded Extension Supplement YR6
$697,907David Eric Gerber · Ut Southwestern Medical Center · UG1 · FY2025 · CA
In silico Safety Pharmacology
$697,903Colleen E Clancy · University Of California At Davis · R01 · FY2019 · HL
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
$697,873William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2018 · HL
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression
$697,850Steven B Abramson · New York University School Of Medicine · R01 · FY2015 · AR
Tailoring Novel Therapeutics for Emerging Drug-Resistant C. Difficile Colitis
$697,754Richard L Guerrant · University Of Virginia · U01 · FY2007 · AI